Wednesday, October 28, 2020
Home India Vaccines Developed Outside India Will Undergo Bridging Studies: Union Health Minister Harsh...

Vaccines Developed Outside India Will Undergo Bridging Studies: Union Health Minister Harsh Vardhan

191 vaccine candidates are in various stages of development across the globe

Union Health Minister Harsh Vardhan on Sunday said that Covid-19 vaccines developed outside India will have to undergo bridging studies to prove their safety and immunogenicity in the Indian population.

“We are open to assessing the feasibility of introducing several Covid-19 vaccines in the country… However, all vaccines that have proven to be safe, immunogenic and efficacious in clinical trials outside India need to undergo bridging studies to prove their safety and immunogenicity in the Indian population as well,” he said.

“Such studies are conducted with much smaller sample size and quickly. A similar approach will be adopted for Covid-19 vaccines which are developed outside the country,” he said during his weekly webinar “Sunday Samvaad”.

Harsh Vardhan’s comment comes as several candidate drugs enter the final phase of testing and trials. Three potential vaccines are being tested in India, including Covishield, which was developed jointly by the Jenner Institute of the University of Oxford and pharma giant AstraZeneca.

Coronavirus vaccine
Several Coronavirus vaccine drugs enter the final phase of testing and trials. Flickr

Covishield is in Phase-2 and Phase-3 human trials and, if successful, will be mass-produced by the Pune-based Serum Institute of India (SII), one of the world’s largest manufacturers of vaccines. Its trials in India are running at 17 locations across the country.

A UK media report earlier this month said Covishield, which is also being tested there, could be cleared by health regulators in that country by end-2020 and be rolled out within six months.

Besides, two other vaccine candidates are also being tested across the country.

Indigenous vaccine developer Bharat Biotech, in collaboration with the Indian Council of Medical Research and the National Institute of Virology, is conducting Phase-1 and Phase-2 clinical trials of candidate COVAXIN.

ALSO READ: 100 Million Infections of Zika Virus Undetected During 2015 Epidemic: Study

The third vaccine candidate under human trial is ZyCoV-D, developed by Zydus Cadila. This candidate is now under Phase-1 and Phase-2 of clinical trials.

The World Health Organisation (WHO) released the ‘Draft landscape of Covid-19 candidate vaccines’, on September 30, in which it informed that as many as 191 vaccine candidates are in various stages of development across the globe. Among these, 41 have made their way into clinical trials while 10 have entered the third phase of clinical trials. (IANS)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,779FollowersFollow

Most Popular

Women Experience Depression Even After 3 Years of Giving Birth

Researchers have found that approximately one in four women experienced high levels of depressive symptoms at some point in the three years after giving...

Lack of Monitoring Stations to Quantify Air Pollution in India

With Delhi facing another tryst with air pollution, several environmental experts believe that the problem goes beyond the national capital and that the country...

Nutritious Snacks for the Virtual School Breaks

The pandemic has forced children to go back to school with virtual learning having swapped classroom teaching. Although school in 2020 may look way...

Books that Address Children’s Mental Health

In these unprecedented times, when isolation fatigue, gloom, and the fear of losing a beloved has also come to grip children, taking care of...

Air Pollution Linked to 15% of COVID Deaths Worldwide

In a major global study, researchers have revealed that long-term exposure to air pollution may be linked to 15 percent of COVID-19 deaths worldwide. According...

Ketogenic Diet could Prevent or Reverse Heart Failure

Heart problems? A special diet might help as researchers have found that the popular and controversial ketogenic diet could completely prevent, or even reverse...

Technology to Produce Psychoactive Drugs by IIT Guwahati

Indian Institute of Technology Guwahati (IIT-G) on Tuesday said its researchers have developed a low-cost membrane technology to produce psychoactive drugs and anti-aging compounds...

Fashion Hubs Burgeon into Fresh Farm Outlets

In recent days, people passing by some of the biggest fashion hubs in Mumbai rub their eyes in disbelief at what they behold. Instead of...

Recent Comments